key: cord-0782847-h3qn1f29
authors: Focosi, Daniele; Iorio, Maria Carla; Lanza, Maria
title: ABO Blood Group Correlations With COVID-19: Cohort Choice Makes A Difference
date: 2020-09-30
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1495
sha: 93f3e031ddd93ef9010a5edd00fe992d6958dfcb
doc_id: 782847
cord_uid: h3qn1f29

nan

M a n u s c r i p t 2 Dear Editor, I read with interest the recent article by Zhao et al reporting the association of blood group A with an increased risk of COVID-19 infection [1] . Many articles have confirmed this association across different continents and ethnicities [2] . In a recent metaanalysis on 31,100 COVID-19 cases, Wu et al reported an increased risk of COVID-19 infection among individuals with A blood group (OR: 1.249) and a decreased risk among individuals with blood group O (OR: 0.699). Additionally, individuals with blood group AB seems to link a higher risk of severity (OR: 2.424) and death (OR: 1.348); individuals with O blood group might had lower risk of severity (OR: 0.748); and individuals with B blood group were likely to relate a lower risk of death [3] .

While the biological basis of this association is still under investigation (virus neutralizing effect of anti-A isoagglutinins against A antigens-covered viral envelopes; exploitation of glycans by SARS-CoV2: surrogate association of blood type with cardiovascular diseases [4] ), it seems that the type of cohort affects the result. In 998 French blood donors with overall low prevalence of neutralizing antibodies (2.7%), the proportion of seropositives was significantly lower in group O donors (1.32% vs 3.86% in donors with other groups), p = 0.014) [5] . Accordingly, using worldwide big data, Liu et al reported that, in comparison with lower blood type A population (< 30%), populations with higher blood type A (≥ 30%) had more infection and death cases in the early exponential phase, higher growth rates, and shorter case doubling time for infection and death [6] . In a meta-regression multivariate analysis including 8.9 million COVID19 cases and 465,000 deaths in a total of 6.8-billion populations, and blood group distribution in 101 worldwide nations, Takagi et al demonstrated that COVID-19 fatality (but not prevalence) was lower in nations with higher blood group O prevalence [7] .

On the contrary, Boudin et al studied 1769 (young and healthy) crewmembers of a single ship (76% prevalence) and found no difference in prevalence or severity for any blood group in this superb model (same time and same place exposure, despite some degree of viral strain variation) [8] .

In our similar experience, 7713 healthy blood donors attending 14 North-Western Tuscany hospitals from June 1 to August 10 were screened for anti-SARS-CoV-2 nucleocapsid (N) IgG using the Abbott Alinity™ platform, according to the manufacturer's recommended index value cutoff of 1.40. As shown in Table 1 , we could not find any increased risk for seropositivity in group A compared to group O donors in this low-prevalence cohort (<1%).

Both patient and healthy donor cohorts are prone to selection biases: while hospital settings include the most severe COVID-19 presentations only and are prone to biased reference population [9] , voluntary blood donors aged 18-65 years who present to donate unaware of any previous disorder likely represent the other end of the spectrum. Further studies are needed to clarify how and how much ABO histo-blood group antigens affect COVID-19 prevalence and severity. In the meanwhile, it is of outmost importance that young adults cannot consider themselves less at risk on the basis of their blood group.

We declare that we have no conflict of interest to disclose.

A c c e p t e d M a n u s c r i p t

Relationship between the ABO Blood Group and the COVID-19

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

ABO(H) blood groups and vascular disease: a systematic review and meta-analysis

ABO blood group predisposes to COVID-19 severity and cardiovascular diseases

Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors

Association between epidemic dynamics of Covid-19 infection and ABO blood group types

Alice in Wonderland of blood groups and COVID-19

ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults

COVID-19 and ABO blood groups

A c c e p t e d M a n u s c r i p t 4